REQUEST A DEMO
Total
USD $0.00
Search more companies

Otkrytoe Aktsionernoe Obschestvo Namangan Dori-Darmon (Uzbekistan)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Otkrytoe Aktsionernoe Obschestvo Namangan Dori-Darmon Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

The company s main activity is import and manufacture of pharmaceutical preparation
The Company s shares were delisted on Uzbekistan Stock Exchange on December 31,2021.

Headquarters
12, Street Nosira, 716000
Namangan; Namangan;

Contact Details: Purchase the Otkrytoe Aktsionernoe Obschestvo Namangan Dori-Darmon report to view the information.

Basic Information
Outstanding Shares:
Purchase the Otkrytoe Aktsionernoe Obschestvo Namangan Dori-Darmon report to view the information.
Financial Auditors:
Purchase the Otkrytoe Aktsionernoe Obschestvo Namangan Dori-Darmon report to view the information.
Incorporation Date:
1996
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after Otkrytoe Aktsionernoe Obschestvo Namangan Dori-Darmon report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UZS. Absolute financial data is included in the purchased report.
Net sales revenue
-35.5%
Total operating revenue
-39.34%
Operating profit (EBIT)
-482.59%
Net Profit (Loss) for the Period
-81.97%
Total assets
-6.28%
Total equity
N/A
Operating Profit Margin (ROS)
-20.46%
Net Profit Margin
-19.39%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.08%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?